Clinical Trials Browser

Phase 3 × Carcinoma, Ductal, Breast × Doxorubicin × Clear all

NCT02125344 2017-07-13

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Phase 3 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT00002967 2013-06-21

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Phase 3 Completed

Breast Neoplasms, Carcinoma, Ductal, Breast